Friday, January 19, 2024 7:37:28 PM
Ron always answers my questions. Translation is issue.
Recently learned the OTC "yield" has more to do with New CEO announced in Sept. Appears previous management had an issue with that.
OTC still asking questions as to management change and previous mgmt. (complaint).
Expects to be resolved soon, but appears cannot file Financials until OTC "recognizes" new management.
Despite that, was told company is still doing very well and all will be OK!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM